Amyloid Neuropathies, Familial
|
|
0.040 |
GeneticVariation
|
BEFREE |
Extremely Early Onset Transthyretin Familial Amyloid Polyneuropathy with a Leu55Pro Mutation: A Pediatric Case Report and Literature Review.
|
31319424 |
2019 |
Amyloid Neuropathies, Familial
|
|
0.040 |
GeneticVariation
|
BEFREE |
The presence of extracellular deposits of amyloid aggregates of WT or L55P TTR, respectively, is a key hallmark of two pathological conditions, known as senile systemic amyloidosis and familial amyloid polyneuropathy.
|
30131519 |
2018 |
Amyloid Neuropathies, Familial
|
|
0.040 |
GeneticVariation
|
BEFREE |
Familial amyloid polyneuropathy in Taiwan: identification of transthyretin variant (Leu55-->Pro).
|
7910950 |
1994 |
Cardiomyopathies
|
|
0.020 |
GeneticVariation
|
BEFREE |
Our study offers new insights on the negative impact of S-homocysteinylation on L55P-TTR stability, whose aggregation is considered the causative agent of a form of early-onset familial amyloid polyneuropathy and cardiomyopathy.
|
31676294 |
2020 |
Cardiomyopathies
|
|
0.020 |
GeneticVariation
|
BEFREE |
The L55P mutation linked to aggressive early onset cardiomyopathy and polyneuropathy induces substantial structural perturbations in both the DAGH and CBEF β-sheets, whereas the V30M polyneuropathy-linked substitution perturbs primarily the CBEF sheet.
|
29972637 |
2018 |
Polyneuropathy
|
|
0.020 |
GeneticVariation
|
BEFREE |
The L55P mutation linked to aggressive early onset cardiomyopathy and polyneuropathy induces substantial structural perturbations in both the DAGH and CBEF β-sheets, whereas the V30M polyneuropathy-linked substitution perturbs primarily the CBEF sheet.
|
29972637 |
2018 |
Amyloidosis
|
|
0.020 |
GeneticVariation
|
BEFREE |
We also demonstrated that clusterin is an effective inhibitor of L55P TTR amyloidosis, the most aggressive form of TTR diseases.
|
19664600 |
2009 |
Amyloidosis
|
|
0.020 |
GeneticVariation
|
BEFREE |
The highly amyloidogenic human TTR variant in which leucine at position 55 is replaced by proline (L55P TTR) is responsible for aggressive fatal amyloidosis with peripheral and autonomic neuropathy, cardiomyopathy and nephropathy.
|
17701470 |
2007 |
Polyneuropathy
|
|
0.020 |
GeneticVariation
|
BEFREE |
The x-ray crystal structure of the amyloidogenic Leu55 --> Pro transthyretin (TTR) variant, implicated as the causative agent in early-onset familial amyloidotic polyneuropathy (Jacobson, D. R., McFarlin, D. E., Kane, I., and Buxbaum, J. N. (1992) Hum.Genet.
|
9733771 |
1998 |
Senile systemic amyloidosis
|
|
0.010 |
GeneticVariation
|
BEFREE |
The presence of extracellular deposits of amyloid aggregates of WT or L55P TTR, respectively, is a key hallmark of two pathological conditions, known as senile systemic amyloidosis and familial amyloid polyneuropathy.
|
30131519 |
2018 |
Renal Insufficiency
|
|
0.010 |
GeneticVariation
|
BEFREE |
This case illustrated the clinical and pathologic phenotype of an ATTR amyloidosis patient who initially presented impaired renal function and p.Leu75Pro variant was found by sequencing the coding region of TTR gene.
|
28272196 |
2017 |
Autonomic neuropathy
|
|
0.010 |
GeneticVariation
|
BEFREE |
The highly amyloidogenic human TTR variant in which leucine at position 55 is replaced by proline (L55P TTR) is responsible for aggressive fatal amyloidosis with peripheral and autonomic neuropathy, cardiomyopathy and nephropathy.
|
17701470 |
2007 |
Kidney Diseases
|
|
0.010 |
GeneticVariation
|
BEFREE |
The highly amyloidogenic human TTR variant in which leucine at position 55 is replaced by proline (L55P TTR) is responsible for aggressive fatal amyloidosis with peripheral and autonomic neuropathy, cardiomyopathy and nephropathy.
|
17701470 |
2007 |
Adenomatous Polyposis Coli
|
|
0.010 |
GeneticVariation
|
BEFREE |
The most common amyloidogenic TTR variant is V30M-TTR, and L55P-TTR is the variant associated with the most aggressive form of FAP.
|
10551861 |
1999 |